Cargando…
Placenta accreta spectrum disorders—experience of management in a German tertiary perinatal centre
PURPOSE: Placenta accreta spectrum (PAS) disorders can cause major intrapartum haemorrhage. The optimal management approach is not yet defined. We analysed available cases from a tertiary perinatal centre to compare the outcome of different individual management strategies. METHODS: A monocentric re...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087589/ https://www.ncbi.nlm.nih.gov/pubmed/33284419 http://dx.doi.org/10.1007/s00404-020-05875-x |
_version_ | 1783686695801061376 |
---|---|
author | Bluth, Anja Schindelhauer, Axel Nitzsche, Katharina Wimberger, Pauline Birdir, Cahit |
author_facet | Bluth, Anja Schindelhauer, Axel Nitzsche, Katharina Wimberger, Pauline Birdir, Cahit |
author_sort | Bluth, Anja |
collection | PubMed |
description | PURPOSE: Placenta accreta spectrum (PAS) disorders can cause major intrapartum haemorrhage. The optimal management approach is not yet defined. We analysed available cases from a tertiary perinatal centre to compare the outcome of different individual management strategies. METHODS: A monocentric retrospective analysis was performed in patients with clinically confirmed diagnosis of PAS between 07/2012 and 12/2019. Electronic patient and ultrasound databases were examined for perinatal findings, peripartum morbidity including blood loss and management approaches such as (1) vaginal delivery and curettage, (2) caesarean section with placental removal versus left in situ and (3) planned, immediate or delayed hysterectomy. RESULTS: 46 cases were identified with an incidence of 2.49 per 1000 births. Median diagnosis of placenta accreta (56%), increta (39%) or percreta (4%) was made in 35 weeks of gestation. Prenatal detection rate was 33% for all cases and 78% for placenta increta. 33% showed an association with placenta praevia, 41% with previous caesarean section and 52% with previous curettage. Caesarean section rate was 65% and hysterectomy rate 39%. In 9% of the cases, the placenta primarily remained in situ. 54% of patients required blood transfusion. Blood loss did not differ between cases with versus without prenatal diagnosis (p = 0.327). In known cases, an attempt to remove the placenta did not show impact on blood loss (p = 0.417). CONCLUSION: PAS should be managed in an optimal setting and with a well-coordinated team. Experience with different approaches should be proven in prospective multicentre studies to prepare recommendations for expected and unexpected need for management. |
format | Online Article Text |
id | pubmed-8087589 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-80875892021-05-05 Placenta accreta spectrum disorders—experience of management in a German tertiary perinatal centre Bluth, Anja Schindelhauer, Axel Nitzsche, Katharina Wimberger, Pauline Birdir, Cahit Arch Gynecol Obstet Maternal-Fetal Medicine PURPOSE: Placenta accreta spectrum (PAS) disorders can cause major intrapartum haemorrhage. The optimal management approach is not yet defined. We analysed available cases from a tertiary perinatal centre to compare the outcome of different individual management strategies. METHODS: A monocentric retrospective analysis was performed in patients with clinically confirmed diagnosis of PAS between 07/2012 and 12/2019. Electronic patient and ultrasound databases were examined for perinatal findings, peripartum morbidity including blood loss and management approaches such as (1) vaginal delivery and curettage, (2) caesarean section with placental removal versus left in situ and (3) planned, immediate or delayed hysterectomy. RESULTS: 46 cases were identified with an incidence of 2.49 per 1000 births. Median diagnosis of placenta accreta (56%), increta (39%) or percreta (4%) was made in 35 weeks of gestation. Prenatal detection rate was 33% for all cases and 78% for placenta increta. 33% showed an association with placenta praevia, 41% with previous caesarean section and 52% with previous curettage. Caesarean section rate was 65% and hysterectomy rate 39%. In 9% of the cases, the placenta primarily remained in situ. 54% of patients required blood transfusion. Blood loss did not differ between cases with versus without prenatal diagnosis (p = 0.327). In known cases, an attempt to remove the placenta did not show impact on blood loss (p = 0.417). CONCLUSION: PAS should be managed in an optimal setting and with a well-coordinated team. Experience with different approaches should be proven in prospective multicentre studies to prepare recommendations for expected and unexpected need for management. Springer Berlin Heidelberg 2020-12-07 2021 /pmc/articles/PMC8087589/ /pubmed/33284419 http://dx.doi.org/10.1007/s00404-020-05875-x Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Maternal-Fetal Medicine Bluth, Anja Schindelhauer, Axel Nitzsche, Katharina Wimberger, Pauline Birdir, Cahit Placenta accreta spectrum disorders—experience of management in a German tertiary perinatal centre |
title | Placenta accreta spectrum disorders—experience of management in a German tertiary perinatal centre |
title_full | Placenta accreta spectrum disorders—experience of management in a German tertiary perinatal centre |
title_fullStr | Placenta accreta spectrum disorders—experience of management in a German tertiary perinatal centre |
title_full_unstemmed | Placenta accreta spectrum disorders—experience of management in a German tertiary perinatal centre |
title_short | Placenta accreta spectrum disorders—experience of management in a German tertiary perinatal centre |
title_sort | placenta accreta spectrum disorders—experience of management in a german tertiary perinatal centre |
topic | Maternal-Fetal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087589/ https://www.ncbi.nlm.nih.gov/pubmed/33284419 http://dx.doi.org/10.1007/s00404-020-05875-x |
work_keys_str_mv | AT bluthanja placentaaccretaspectrumdisordersexperienceofmanagementinagermantertiaryperinatalcentre AT schindelhaueraxel placentaaccretaspectrumdisordersexperienceofmanagementinagermantertiaryperinatalcentre AT nitzschekatharina placentaaccretaspectrumdisordersexperienceofmanagementinagermantertiaryperinatalcentre AT wimbergerpauline placentaaccretaspectrumdisordersexperienceofmanagementinagermantertiaryperinatalcentre AT birdircahit placentaaccretaspectrumdisordersexperienceofmanagementinagermantertiaryperinatalcentre |